CLAIRE SCHACK: Open Payments
NPI 1003468968 · VERSAILLES, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,037 in 78 payments from 15 companies in 2025. Trend: 2023 $2,416 · 2024 $861 · 2025 $1,037
Food & beverage: $1,037
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $308 |
| ABBVIE INC. | 31 | $226 |
| Axsome Therapeutics, Inc. | 3 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| Indivior Inc. | 3 | $55 |
| Grifols USA, LLC | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Edwards Lifesciences Corporation | 1 | $23 |
Products named: CAPLYTA, VRAYLAR, Auvelity, GLASSIA, SUBLOCADE, Prolastin-C Liquid, FANAPT, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
